JKN2403

· Joincare Pharmaceutical Group Industry Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JKN2403, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD [Phase 2]